REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
REVELATION BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.29+2.80 (+577.76%)
Close on Oct 19, 2026
- Market cap
- $12.58M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Revelation Biosciences has not reported a dividend
No dividend per share appears in Revelation Biosciences's annual filings since fiscal 2019.